Evolent Health PE Ratio 2014-2025 | EVH
Current and historical p/e ratio for Evolent Health (EVH) from 2014 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Evolent Health PE ratio as of January 15, 2026 is 0.00.
| Evolent Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-15 | 3.94 | 0.00 | |
| 2025-09-30 | 8.46 | $-1.58 | 0.00 |
| 2025-06-30 | 11.26 | $-1.61 | 0.00 |
| 2025-03-31 | 9.47 | $-1.23 | 0.00 |
| 2024-12-31 | 11.25 | $-0.82 | 0.00 |
| 2024-09-30 | 28.28 | $-0.91 | 0.00 |
| 2024-06-30 | 19.12 | $-0.94 | 0.00 |
| 2024-03-31 | 32.79 | $-1.25 | 0.00 |
| 2023-12-31 | 33.03 | $-1.27 | 0.00 |
| 2023-09-30 | 27.23 | $-1.02 | 0.00 |
| 2023-06-30 | 30.30 | $-0.70 | 0.00 |
| 2023-03-31 | 32.45 | $-0.38 | 0.00 |
| 2022-12-31 | 28.08 | $-0.20 | 0.00 |
| 2022-09-30 | 35.93 | $-0.15 | 0.00 |
| 2022-06-30 | 30.71 | $-0.32 | 0.00 |
| 2022-03-31 | 32.30 | $-0.38 | 0.00 |
| 2021-12-31 | 27.67 | $-0.44 | 0.00 |
| 2021-09-30 | 31.00 | $-0.55 | 0.00 |
| 2021-06-30 | 21.12 | $-0.84 | 0.00 |
| 2021-03-31 | 20.20 | $-3.11 | 0.00 |
| 2020-12-31 | 16.03 | $-3.91 | 0.00 |
| 2020-09-30 | 12.41 | $-6.10 | 0.00 |
| 2020-06-30 | 7.12 | $-5.96 | 0.00 |
| 2020-03-31 | 5.43 | $-3.96 | 0.00 |
| 2019-12-31 | 9.05 | $-3.63 | 0.00 |
| 2019-09-30 | 7.19 | $-1.48 | 0.00 |
| 2019-06-30 | 7.95 | $-1.34 | 0.00 |
| 2019-03-31 | 12.58 | $-1.09 | 0.00 |
| 2018-12-31 | 19.95 | $-0.68 | 0.00 |
| 2018-09-30 | 28.40 | $-0.65 | 0.00 |
| 2018-06-30 | 21.05 | $-0.67 | 0.00 |
| 2018-03-31 | 14.25 | $-0.82 | 0.00 |
| 2017-12-31 | 12.30 | $-0.98 | 0.00 |
| 2017-09-30 | 17.80 | $-1.13 | 0.00 |
| 2017-06-30 | 25.35 | $-1.21 | 0.00 |
| 2017-03-31 | 22.30 | $-1.13 | 0.00 |
| 2016-12-31 | 14.80 | $-3.70 | 0.00 |
| 2016-09-30 | 24.62 | $-3.47 | 0.00 |
| 2016-06-30 | 19.20 | $-3.50 | 0.00 |
| 2016-03-31 | 10.56 | $6.43 | 1.64 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.435B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.977B | 41.61 |
| Tempus AI (TEM) | United States | $12.325B | 0.00 |
| Doximity (DOCS) | United States | $7.582B | 31.22 |
| Hims & Hers Health (HIMS) | United States | $7.130B | 58.00 |
| IRHYTHM HLDGS (IRTC) | United States | $5.259B | 0.00 |
| Hinge Health (HNGE) | United States | $3.411B | 0.00 |
| Heartflow (HTFL) | United States | $2.979B | 0.00 |
| Privia Health (PRVA) | United States | $2.811B | 175.77 |
| Inspire Medical Systems (INSP) | United States | $2.704B | 44.74 |
| 10x Genomics (TXG) | United States | $2.647B | 0.00 |
| Omnicell (OMCL) | United States | $2.276B | 46.53 |
| Azenta (AZTA) | United States | $1.817B | 74.53 |
| Clover Health Investments (CLOV) | United States | $1.452B | 0.00 |
| Enovis (ENOV) | United States | $1.388B | 7.29 |
| Schrodinger (SDGR) | United States | $1.350B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.250B | 0.00 |
| Phreesia (PHR) | United States | $0.971B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.865B | 0.00 |
| Talkspace (TALK) | United States | $0.628B | 126.33 |
| Standard BioTools (LAB) | United States | $0.611B | 0.00 |
| Claritev (CTEV) | United States | $0.504B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.348B | 0.00 |
| Carlsmed (CARL) | United States | $0.339B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 15.14 |
| Zepp Health (ZEPP) | Netherlands | $0.299B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.293B | 0.00 |
| CapsoVision (CV) | United States | $0.276B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.258B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.196B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.174B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.169B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.122B | 6.67 |
| Outset Medical (OM) | United States | $0.099B | 0.00 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| HeartBeam (BEAT) | United States | $0.079B | 0.00 |
| American Well (AMWL) | United States | $0.077B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.072B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.050B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.042B | 0.00 |
| Precipio (PRPO) | United States | $0.042B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.023B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |